In the phase 3 SUMMIT trial, tirzepatide, was found to reduce the risk for worsening heart failure in patients with preserved ...

In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...

An analysis of more than 5,300 patients with MS shows that access to early treatment in MS varies, though those with ...

I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial,” published in ...

Winter affects sleep schedules through daylight shifts, reduced sunlight, and seasonal illness, negatively impacting sleep ...

The following is a summary of “Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A ...

The following is a summary of “Characterization of changes in the resting-state intrinsic network in patients with diabetic ...

The following is a summary of “Association between early anti-cytomegalovirus therapy and the incidence of chronic ...

Results from the GLORIOUS trial indicated that exenatide did not decrease mortality or severe organ injury among patients who ...

In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...

The following is a summary of “Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension,” published in the November 2024 issue of Cardiology by Reddy et ...

The following is a summary of “Using the Socioecological Model to Understand Medical Staff and Older Adult Patients’ ...